
NMTC P/E Ratio
P/E Ratio as of Jul 11, 2025: -3.12
Average-2.97
Median-3.02
Minimum-3.28
Maximum-2.46
-3.12
Past Month-0.57 (22.35%)
The P/E ratio for NMTC is -3.12 as of Jul 11, 2025. This represents a increase of 34.48% compared to its 12-month average P/E ratio of -2.32. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
NeuroOne Medical Technologies Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
NeuroOne Medical Technologies Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing NeuroOne Medical Technologies Corp to industry peers.
NeuroOne Medical Technologies Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
NeuroOne Medical Technologies Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing NeuroOne Medical Technologies Corp to industry peers.
NMTC P/E Ratio Insights
See NeuroOne Medical Technologies Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NMTC
Order type
Buy in
Order amount
Est. shares
0 shares
NMTC P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $0.70 | -3.07 |
Jun 2, 2025 | $0.5929 | -2.60 |
May 1, 2025 | $0.618 | -2.33 |
Apr 1, 2025 | $0.8698 | -3.28 |
Mar 3, 2025 | $1.07 | -4.03 |
Feb 3, 2025 | $1.08 | -2.33 |
Jan 2, 2025 | $0.8248 | -1.78 |
NMTC End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -3.12 | +75.28% |
2024 | -1.78 | -26.45% |
2023 | -2.42 | +26.04% |
2022 | -1.92 | +27.15% |
2021 | -1.51 | -37.34% |
2020 | -2.41 | — |
FAQs About NeuroOne Medical Technologies Corp (NMTC) P/E ratio
The latest P/E ratio of NMTC is -3.12, as of Jul 11, 2025. This is calculated based on its current stock price and earnings per share (EPS).
NeuroOne Medical Technologies Corp’s last 12-month average P/E ratio is -2.32, compared to its current P/E ratio of -3.12. This reflects a increase of 34.48%.
NeuroOne Medical Technologies Corp’s current P/E ratio of -3.12 is higher than its last 12-month average P/E of -2.32. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
NeuroOne Medical Technologies Corp’s average P/E ratio over the last 3 years is -2.17. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
NeuroOne Medical Technologies Corp’s average P/E ratio over the last 5 years is -2.24. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.